MAERSK announced the signing of a logistics agreement with Novo Nordisk from 2021. The three-year agreement on cold chain logistics covers transportation including ocean services and inland logistics.

Vincent Clerc, CEO ocean and logistics at Maersk said, “We are proud to be chosen as one of Novo Nordisk´s main logistic companies.

“Transporting pharmaceuticals on a global level is a demanding task with various complexities that require flexible and resilient supply chains as well as digital and eco-friendly solutions.

“This achievement showcases the rapid transformation of A.P. Moller – Maersk as a modern end-to-end logistics company with fully controlled assets.”

One of the largest pharmaceutical companies in the world, Novo Nordisk has chosen Maersk´s ECO Delivery to reduce the carbon footprint in transportation. The initiative uses sustainable biofuel to power selected Maersk-vessels and helps Novo Nordisk to make progress towards its ambitious sustainability goals.

Rune Sylow, corporate vice president, strategic sourcing at Novo Nordisk said, “Our ambition of achieving zero environmental impact is a cornerstone of our aspiration to be a truly sustainable business.

“We consider A.P. Moller – Maersk to be the right global distribution partner to secure the steady, environmentally friendly delivery of our high-value shipments and we look forward to the collaboration.”

The global agreement will enter effect as of 1st April 2021.